P657-0851 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine

P657-0851 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine
P657-0851 Screening compound: 1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P657-0851
1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P657-0851

Molecular Formula

C17H24N4O4S (C17 H24 N4 O4 S)

Compound Name

1-{[5-(5-cyclobutyl-1,3,4-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine

IUPAC name

1-{[5-(5-cyclobutyl-134-oxadiazol-2-yl)furan-2-yl]sulfonyl}-4-(propan-2-yl)piperazine

SMILES

CC(C)N(CC1)CCN1S(c1ccc(-c2nnc(C3CCC3)o2)o1)(=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

380.47

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.931

Distribution Coefficient, logD

1.687

Water Solubility, LogSw

-2.31

Polar Surface Area

75.472

Acid Dissociation Constant (pKa)

26.75

Base Dissociation Constant (pKb)

7.28

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

64.70

P657-0851 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Others
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with P657-0851 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P657-0851?
Check Price and Availability of P657-0851, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P657-0851 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P657-0851
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P657-0851
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P657-0851 available by request